GKBMedical Equipment & Supplies
GKB Ophthalmics Ltd — Profit & Loss Statement
₹52.50
-10.19%
GKB Ophthalmics Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 95449.07 | 1855.92 | — |
| Tax Rate For Calcs | 0.30 | 0.30 | 0.17 | 0.00 | — |
| Normalized EBITDA | -1.27 Cr | 2.03 Cr | 4.21 Cr | 5.58 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | -7.04 Cr | -2.81 Cr | -0.17 Cr | 1.27 Cr | — |
| Reconciled Depreciation | 3.09 Cr | 2.90 Cr | 2.83 Cr | 2.67 Cr | — |
| Reconciled Cost Of Revenue | 73.45 Cr | 59.74 Cr | 51.29 Cr | 48.12 Cr | — |
| EBITDA | -1.27 Cr | 2.03 Cr | 4.26 Cr | 5.73 Cr | — |
| EBIT | -4.36 Cr | -0.87 Cr | 1.43 Cr | 3.06 Cr | — |
| Net Interest Income | -2.37 Cr | -1.90 Cr | -1.07 Cr | -0.97 Cr | — |
| Interest Expense | 2.37 Cr | 1.90 Cr | 1.30 Cr | 1.11 Cr | — |
| Normalized Income | -7.04 Cr | -2.81 Cr | -0.22 Cr | 1.12 Cr | — |
| Net Income From Continuing And Discontinued Operation | -7.04 Cr | -2.81 Cr | -0.17 Cr | 1.27 Cr | — |
| Total Expenses | 114.86 Cr | 90.57 Cr | 74.49 Cr | 68.41 Cr | — |
| Diluted Average Shares | 0.50 Cr | 0.50 Cr | 0.50 Cr | 0.50 Cr | — |
| Basic Average Shares | 0.50 Cr | 0.50 Cr | 0.50 Cr | 0.50 Cr | — |
| Diluted EPS | -13.98 | -5.58 | -0.33 | 2.53 | — |
| Basic EPS | -13.98 | -5.58 | -0.33 | 2.53 | — |
| Diluted NI Availto Com Stockholders | -7.04 Cr | -2.81 Cr | -0.17 Cr | 1.27 Cr | — |
| Net Income Common Stockholders | -7.04 Cr | -2.81 Cr | -0.17 Cr | 1.27 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | -7.04 Cr | -2.81 Cr | -0.17 Cr | 1.27 Cr | — |
| Minority Interests | 0.03 Cr | 0.17 Cr | -0.28 Cr | -0.67 Cr | — |
| Net Income Including Noncontrolling Interests | -7.08 Cr | -2.98 Cr | 0.12 Cr | 1.94 Cr | — |
| Net Income Continuous Operations | -7.08 Cr | -2.98 Cr | 0.12 Cr | 1.94 Cr | — |
| Tax Provision | 0.35 Cr | 0.21 Cr | 0.02 Cr | 24000.00 | — |
| Pretax Income | -6.73 Cr | -2.78 Cr | 0.14 Cr | 1.95 Cr | — |
| Other Non Operating Income Expenses | 1.33 Cr | 1.51 Cr | 0.10 Cr | 0.14 Cr | — |
| Net Non Operating Interest Income Expense | -2.37 Cr | -1.90 Cr | -1.07 Cr | -0.97 Cr | — |
| Interest Expense Non Operating | 2.37 Cr | 1.90 Cr | 1.30 Cr | 1.11 Cr | — |
| Operating Income | -5.87 Cr | -2.32 Cr | 0.89 Cr | 2.33 Cr | — |
| Operating Expense | 41.41 Cr | 30.84 Cr | 23.20 Cr | 20.29 Cr | — |
| Other Operating Expenses | 21.07 Cr | 14.18 Cr | 4.87 Cr | 4.50 Cr | — |
| Depreciation And Amortization In Income Statement | 3.09 Cr | 2.90 Cr | 2.83 Cr | 2.67 Cr | — |
| Depreciation Income Statement | 3.09 Cr | 2.90 Cr | 2.83 Cr | 2.67 Cr | — |
| Gross Profit | 35.54 Cr | 28.52 Cr | 24.09 Cr | 22.62 Cr | — |
| Cost Of Revenue | 73.45 Cr | 59.74 Cr | 51.29 Cr | 48.12 Cr | — |
| Total Revenue | 108.99 Cr | 88.25 Cr | 75.38 Cr | 70.75 Cr | — |
| Operating Revenue | 108.99 Cr | 88.25 Cr | 75.38 Cr | 70.75 Cr | — |
| Total Unusual Items | — | 0.04 Cr | 0.06 Cr | 0.15 Cr | -0.99 Cr |
| Total Unusual Items Excluding Goodwill | — | 0.04 Cr | 0.06 Cr | 0.15 Cr | -0.99 Cr |
| Interest Income | — | 0.89 Cr | 0.60 Cr | 0.51 Cr | 0.23 Cr |
| Rent Expense Supplemental | — | 2.00 Cr | 1.87 Cr | 1.53 Cr | 1.29 Cr |
| Special Income Charges | — | 0.04 Cr | 0.06 Cr | 0.14 Cr | -1.00 Cr |
| Other Special Charges | — | -0.04 Cr | -0.06 Cr | -0.14 Cr | 1.00 Cr |
| Total Other Finance Cost | — | 0.52 Cr | 0.38 Cr | 0.37 Cr | 0.89 Cr |
| Interest Income Non Operating | — | 0.89 Cr | 0.60 Cr | 0.51 Cr | 0.23 Cr |
| Amortization | — | 12000.00 | 19000.00 | 26000.00 | 37000.00 |
| Selling General And Administration | — | 3.53 Cr | 2.57 Cr | 2.29 Cr | 1.98 Cr |
| Selling And Marketing Expense | — | 2.30 Cr | 1.42 Cr | 1.22 Cr | 1.04 Cr |
| General And Administrative Expense | — | 1.22 Cr | 1.15 Cr | 1.07 Cr | 0.93 Cr |
| Rent And Landing Fees | — | 2.00 Cr | 1.87 Cr | 1.53 Cr | 1.29 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on GKB Ophthalmics Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.